Collaborative Agreements

6 Months Ended

Jun. 30, 2017

Collaborative Agreements [Abstract]

Collaborative Agreements

9. Collaborative Agreements

In 2013, the Company entered into a Collaboration Agreement and a License Agreement with the University of Leicester (the “Leicester Agreements”). Under the Leicester Agreements, the Company provided payments to carry out research on the University of Leicester’s development of a bacteriophage therapeutic to resolve C. difficile infections and licensed related patents, materials and know-how.  During the three and six months ended June 30, 2017, the Company recorded $3,000 and $79,000 respectively, in research and development expenses related to the agreements.  During the three and six months ended June 30, 2016, the Company recorded $43,000 and $86,000, respectively, in research and development expenses related to the Leicester Agreements.  In March 2017, the Company provided the required 180 days’ notice to terminate the Leicester Collaboration Agreement.  In June 2017, the Company provided the required 60 days’ notice to terminate the Leicester License Agreement. The termination of the Leicester License Agreement was not material to the Company.